Cancer Causes & Control

, Volume 16, Issue 8, pp 965–973 | Cite as

Hormone Replacement Therapy, Reproductive History, and Colorectal Adenomas: Data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States)

  • Mark P. PurdueEmail author
  • Pamela J. Mink
  • Patricia Hartge
  • Wen-Yi Huang
  • Saundra Buys
  • Richard B. Hayes



Findings from some epidemiologic studies of colorectal cancer and adenoma suggest that the protective effect of post-menopausal hormone replacement therapy (HRT) may differ across categories of age and body mass index (BMI). We conducted an analysis of women participating in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial to investigate the relationship between HRT use and prevalent adenoma, both overall and across different population subgroups.


Women aged 55–74 were randomized to screening by flexible sigmoidoscopy at ten PLCO screening centers between September 1993 and September 2001. We identified 1468 women with at least one left-sided adenoma and 19,203 without adenoma or colorectal cancer. Information about HRT and reproductive factors was obtained from a self-administered questionnaire.


Compared to never use of HRT, current use was associated with a decreased prevalence of left-sided adenoma (odds ratio (OR) 0.85; 95% confidence interval (CI) 0.75–0.97). We found no evidence of dose–response with increasing duration of use for current or former users. The association with current HRT use was stronger among women aged 65+ (OR 0.69; 95% CI 0.56–0.84), with a BMI<30 (OR 0.82; 95% CI 0.71–0.95) and who regularly use aspirin or ibuprofen (OR 0.77; 95% CI 0.65–0.91). Other reproductive factors were not significantly associated with adenoma prevalence.


Our findings suggest that current HRT use may protect against colorectal adenoma, and that this protective effect is short-lived following cessation of use.

Key words

adenoma colorectal neoplasms hormone replacement therapy mass screening 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dales, LG, Friedman, GD, Ury, HK, Grossman, S, Williams, SR 1979A case-control study of relationships of diet and other traits to colorectal cancer in American blacksAm J Epidemiol109132144PubMedGoogle Scholar
  2. 2.
    Bjelke, E 1974Colorectal cancer: clues from epidemiologyExcerpta Med Foudation Int Congr6324330Google Scholar
  3. 3.
    Fraumeni, JF,Jr, Lloyd, JW, Smith, EM, Wagoner, JK 1969Cancer mortality among nuns: role of marital status in etiology of neoplastic disease in womenJ Natl Cancer Inst42455468PubMedGoogle Scholar
  4. 4.
    McMichael, AJ, Potter, JD 1980Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesisJ Natl Cancer Inst6512011207PubMedGoogle Scholar
  5. 5.
    Grodstein, F, Newcomb, PA, Stampfer, MJ 1999Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysisAm J Med106574582CrossRefPubMedGoogle Scholar
  6. 6.
    Chlebowski, RT, Wactawski-Wende, J, Ritenbaugh, C 2004Estrogen plus progestin and colorectal cancer in postmenopausal womenN Engl J Med3509911004CrossRefPubMedGoogle Scholar
  7. 7.
    Slattery, ML, Ballard-Barbash, R, Edwards, S, Caan, BJ, Potter, JD 2003Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States)Cancer Causes Control147584CrossRefPubMedGoogle Scholar
  8. 8.
    Issa, JP, Ottaviano, YL, Celano, P, Hamilton, SR, Davidson, NE, Baylin, SB 1994Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNat Genet7536540CrossRefPubMedGoogle Scholar
  9. 9.
    Potter, JD, Bostick, RM, Grandits, GA 1996Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control StudyCancer Epidemiol Biomarkers Prev5779784PubMedGoogle Scholar
  10. 10.
    Jacobson, JS, Neugut, AI, Garbowski, GC 1995Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States)Cancer Causes Control6513518CrossRefPubMedGoogle Scholar
  11. 11.
    Peipins, LA, Newman, B, Sandler, RS 1997Reproductive history, use of exogenous hormones, and risk of colorectal adenomasCancer Epidemiol Biomarkers Prev6671675PubMedGoogle Scholar
  12. 12.
    Platz, EA, Martinez, ME, Grodstein, F 1997Parity and other reproductive factors and risk of adenomatous polyps of the distal colorectum (United States)Cancer Causes Control8894903CrossRefPubMedGoogle Scholar
  13. 13.
    Grodstein, F, Martinez, ME, Platz, EA 1998Postmenopausal hormone use and risk for colorectal cancer and adenomaAnn Int Med128705712PubMedGoogle Scholar
  14. 14.
    Woodson, K, Lanza, E, Tangrea, JA 2001Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention TrialJ Natl Cancer Inst9317991805CrossRefPubMedGoogle Scholar
  15. 15.
    Kampman, E, Potter, JD, Slattery, ML, Caan, BJ, Edwards, S 1997Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United StatesCancer Causes Control8146158CrossRefPubMedGoogle Scholar
  16. 16.
    Prihartono, N, Palmer, JR, Louik, C, Shapiro, S, Rosenberg, L 2000A case-control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancerCancer Epidemiol Biomarkers Prev9443447PubMedGoogle Scholar
  17. 17.
    Newcomb, PA, Storer, BE 1995Postmenopausal hormone use and risk of large-bowel cancerJ Natl Cancer Inst8710671071PubMedGoogle Scholar
  18. 18.
    Terry, MB, Neugut, AI, Bostick, RM 2002Risk factors for advanced colorectal adenomas: a pooled analysisCancer Epidemiol Biomarkers Prev11622629PubMedGoogle Scholar
  19. 19.
    Gohagan, JK, Prorok, PC, Hayes, RB, Kramer, BS 2000The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and statusControl Clin Trials21251S272SCrossRefPubMedGoogle Scholar
  20. 20.
    Hayes, RB, Reding, D, Kopp, W 2000Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialControl Clin Trials21349S355SCrossRefPubMedGoogle Scholar
  21. 21.
    Anderson, GL, Limacher, M, Assaf, AR 2004Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Womenȁ9s Health Initiative randomized controlled trialJAMA29117011712PubMedGoogle Scholar
  22. 22.
    Persson, I, Yuen, J, Bergkvist, L, Schairer, C 1996Cancer incidence and mortality in women receiving estrogen and estrogen–progestin replacement therapy – long-term follow-up of a Swedish cohortInt J Cancer67327332CrossRefPubMedGoogle Scholar
  23. 23.
    Troisi, R, Schairer, C, Chow, WH, Schatzkin, A, Brinton, LA, Fraumeni, JF,Jr 1997A prospective study of menopausal hormones and risk of colorectal cancer (United States)Cancer Causes Control8130138CrossRefPubMedGoogle Scholar
  24. 24.
    Jacobs, EJ, White, E, Weiss, NS 1994Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA)Cancer Causes Control5359366CrossRefPubMedGoogle Scholar
  25. 25.
    Potter, JD, McMichael, AJ 1983Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control studyJ Natl Cancer Inst71703709PubMedGoogle Scholar
  26. 26.
    Hou L, Ji B-T, Blair A (2004) Menopausal modification effect on the association between overweight and colon cancer risk in Chinese women. J Natl Cancer Inst.Google Scholar
  27. 27.
    Calle, EE, Miracle-McMahill, HL, Thun, MJ, Heath, CW,Jr 1995Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal womenJ Natl Cancer Inst87517523PubMedGoogle Scholar
  28. 28.
    Verkasalo, PK, Thomas, HV, Appleby, PN, Davey, GK, Key, TJ 2001Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom)Cancer Causes Control124759CrossRefPubMedGoogle Scholar
  29. 29.
    Yu, H, Rohan, T 2000Role of the insulin-like growth factor family in cancer development and progressionJ Natl Cancer Inst9214721489CrossRefPubMedGoogle Scholar
  30. 30.
    Lointier, P, Wildrick, DM, Boman, BM 1992The effects of steroid hormones on a human colon cancer cell line in vitroAnticancer Res1213271330PubMedGoogle Scholar
  31. 31.
    Foley, EF, Jazaeri, AA, Shupnik, MA, Jazaeri, O, Rice, LW 2000Selective loss of estrogen receptor beta in malignant human colonCancer Res60245248PubMedGoogle Scholar
  32. 32.
    Oshima, CT, Wonraht, DR, Catarino, RM, Mattos, D, Forones, NM 1999Estrogen and progesterone receptors in gastric and colorectal cancerHepatogastroenterology4631553158PubMedGoogle Scholar
  33. 33.
    Hendrickse, CW, Jones, CE, Donovan, IA, Neoptolemos, JP, Baker, PR 1993Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell linesBr J Surg80636640PubMedGoogle Scholar
  34. 34.
    Singh, S, Poulsom, R, Hanby, AM 1998Expression of oestrogen receptor and oestrogen-inducible genes pS2 and ERD5 in large bowel mucosa and cancerJ Pathol184153160CrossRefPubMedGoogle Scholar
  35. 35.
    Schwartz, B, Smirnoff, P, Shany, S, Liel, Y 2000Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colonMol Cell Biochem2038793CrossRefPubMedGoogle Scholar
  36. 36.
    Smirnoff, P, Liel, Y, Gnainsky, J, Shany, S, Schwartz, B 1999The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptorOncol Res11255264PubMedGoogle Scholar
  37. 37.
    Colin, EM, Bemd, GJ, Aken, M 1999Evidence for involvement of 17beta-estradiol in intestinal calcium absorption independent of 1,25-dihydroxyvitamin D3 level in the ratJ Bone Miner Res145764PubMedGoogle Scholar
  38. 38.
    Avioli, LV, McDonald, JE, Lee, SW 1965The influence of age on the intestinal absorption of 47-Ca absorption in post-menopausal osteoporosisJ Clin Invest4419601907PubMedGoogle Scholar
  39. 39.
    Bullamore, JR, Wilkinson, R, Gallagher, JC, Nordin, BE, Marshall, DH 1970Effect of age on calcium absorptionLancet2535537CrossRefPubMedGoogle Scholar
  40. 40.
    Chan, AT 2003Aspirin, non-steroidal anti-inflammatory drugs and colorectal neoplasia: future challenges in chemopreventionCancer Causes Control14413418CrossRefPubMedGoogle Scholar
  41. 41.
    Lieberman, DA, Prindiville, S, Weiss, DG, Willett, W 2003Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individualsJAMA29029592967CrossRefPubMedGoogle Scholar
  42. 42.
    Tangrea, JA, Albert, PS, Lanza, E 2003Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)Cancer Causes Control14403411CrossRefPubMedGoogle Scholar
  43. 43.
    Sandler, RS, Galanko, JC, Murray, SC, Helm, JF, Woosley, JT 1998Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomasGastroenterology114441447PubMedGoogle Scholar
  44. 44.
    Martin, C, Connelly, A, Keku, TO 2002Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomasGastroenterology12317701777CrossRefPubMedGoogle Scholar
  45. 45.
    Egan, KM, Lawson, JA, Fries, S 2004COX-2-derived prostacyclin confers atheroprotection on female miceScience30619541957CrossRefPubMedGoogle Scholar
  46. 46.
    Tamura, M, Deb, S, Sebastian, S, Okamura, K, Bulun, SE 2004Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cellsFertil Steril8113511356CrossRefPubMedGoogle Scholar
  47. 47.
    Akarasereenont, P, Techatraisak, K, Thaworn, A, Chotewuttakorn, S 2000The induction of cyclooxygenase-2 by 17beta-estradiol in endothelial cells is mediated through protein kinase CInflamm Res49460465CrossRefPubMedGoogle Scholar
  48. 48.
    Potter, JD, Slattery, ML, Bostick, RM, Gapstur, SM 1993Colon cancer: a review of the epidemiologyEpidemiol Rev15499545PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Mark P. Purdue
    • 1
    Email author
  • Pamela J. Mink
    • 1
    • 2
  • Patricia Hartge
    • 1
  • Wen-Yi Huang
    • 1
  • Saundra Buys
    • 3
  • Richard B. Hayes
    • 1
  1. 1.Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and GeneticsNational Cancer InstituteRockvilleUSA
  2. 2.Division of Cancer PreventionNational Cancer InstituteRockvilleUSA
  3. 3.University of Utah Health Sciences CenterSalt Lake CityUSA

Personalised recommendations